Pet Mri Systems Market Will Grow At The Highest Pace Owing To Growing Incidence Of Cancer Cases

By Author: Ravina Pandya
Total Articles: 28
Comment this article

The PET MRI systems market has been witnessing significant growth over the past few years owing to the increasing adoption of hybrid imaging technology, demand for non-invasive diagnostic techniques, and rising incidence of cancer cases. PET MRI combines positron emission tomography (PET) and magnetic resonance imaging (MRI) technologies to provide both anatomical and functional information of the human body. This hybrid technique aids in accurate diagnosis and localization of cancerous tissues. Additionally, PET MRI overcomes limitations of standalone PET and MRI scans by correlating biochemical and structural changes during a single scanning session. It also eliminates misregistration errors which are commonly observed in sequential PET-CT imaging.

The PET MRI systems market is estimated to be valued at USD 126.7 Mn in 2024 and is expected to reach USD 236.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031.
Rising prevalence of chronic diseases such as cancer is a key factor driving the growth of this market. According to the World Cancer Research Fund International, globally ...
... cancer burden is projected to reach 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Advanced diagnostic techniques such as PET MRI play a crucial role in effective cancer diagnosis, treatment monitoring, and recurrence detection.

Key Takeaways

Key players operating in the PET MRI systems market are Siemens Healthcare GmbH, Philips Healthcare, and GE Healthcare.

Second paragraph is talking about the key growing demand in market: Rising demand for minimally invasive diagnostic procedures and advantages of PET MRI over standalone PET and MRI systems are fueling the adoption of PET MRI Systems Market globally. The hybrid technique eliminates misregistration concerns and provides molecular and anatomical data simultaneously, aiding precise diagnosis and treatment management.
Third paragraph is talking about technological advancement of market: Technological advancements in PET MRI technologies such as development of time-of-flight PET and Deep Learning algorithms are increasing imaging quality and speed. Manufacturers are actively integrating MRI capabilities such as diffusion weighted imaging (DWI) and dynamic contrast enhanced (DCE) with PET to offer multi-parametric cancer imaging.

Market Trends

One of the key trends in the PET MRI systems market is the increased adoption of whole-body PET MRI systems. These systems provide both anatomical as well as functional information of the entire human body in a single session without moving the patient between PET and MRI sections. This simplifies clinical workflows and decreases diagnosis time. Another major trend is the growing popularity of UHF (ultra-high field) MRI scanners integrated with PET. UHF MRI offers superior soft tissue contrast and functional details. Hence, combining UHF MRI with PET imaging modality improves cancer lesion visualization.

Market Opportunities

Rising incidence of cancers globally presents significant opportunities for players in the PET MRI systems market. According to the American Cancer Society, over 1.8 million new cancer cases are expected to be diagnosed in the US in 2022. Emerging markets such as China, India, Brazil, Mexico also present lucrative prospects owing to increasing healthcare investments in these countries. Growing application of PET MRI in neurological disorders will further boost market revenues during the forecast period.

Impact of COVID-19 on the PET MRI Systems Market

The COVID-19 pandemic has significantly affected the PET MRI Systems market. In the initial phase of the pandemic, several elective diagnostic imaging procedures were postponed to avoid unnecessary exposure and reserve medical resources for critical COVID-19 cases. This led to a steep decline in the installation and utilization of PET MRI systems. However, PET imaging plays a vital role in the diagnosis and management of various cancers. With the resumption of non-COVID healthcare activities, the demand for PET MRI systems is gradually increasing.

Many healthcare organizations and researchers are investigating the potential of PET/MRI to gain insights into the pathogenesis of COVID-19 and its long term effects. Some studies have utilized PET/MRI scans to assess pulmonary inflammation and myocardial involvement in COVID-19 patients. This is expected to further drive the adoption of PET MRI systems in the coming years.

As the pandemic situation stabilizes, original equipment manufacturers and healthcare providers will need to focus on strategies to make up for the lost time during the lockdowns. Increasing investments in medical research utilizing PET/MRI technique can potentially help understand COVID-19 better. Development of portable and less expensive PET/MRI systems may enable more widespread use. Collaborations between industry and academia can help foster innovation and accelerate recovery.

North America accounts for the largest share of the PET MRI Systems market in terms of value. This can be attributed to factors such as presence of leading OEMs, high healthcare spending, availability of reimbursements and rising incidence of cancer. Asia Pacific region is expected to be the fastest growing market owing to increasing patient affordability, growing medical tourism and rising government initiatives to modernize healthcare infrastructure. Countries like China and India are expected to offer significant growth opportunities for PET MRI Systems market players.
Get More Insights On- PET MRI Systems Market

About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)